JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
TWAV
TaoWeave, Inc.
There isn't enough reported data to score TWAV yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
TWAV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
TWAV's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like TWAV.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
TWAV PE Valuation
TWAV has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
TWAV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect TWAV's revenue to decline, with its earnings and profitability holding steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus TWAV down 101%.
TWAV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$91.78 | +$334.22 |
| Q2 2023 | -$217.78 | +$82.22 |
| Q1 2023 | -$360.58 | -$186.58 |
| Q4 2022 | -$426.58 | -$204.58 |
| Q3 2022 | -$426.00 | -$330.00 |
| Q2 2022 | -$300.00 | +$24.00 |
| Q1 2022 | -$174.00 | +$492.00 |
| Q4 2021 | -$222.00 | +$666.00 |
TWAV lost $2.20 per share over the past year, a smaller loss than the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over TWAV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over TWAV on profitability, with a higher operating margin.
TWAV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $522K | -12% |
| Q1 2026 | $707K | +14% |
| Q4 2025 | $622K | +10% |
| Q3 2025 | $601K | +4% |
| Q2 2025 | $592K | -3.1% |
| Q1 2025 | $622K | -0.6% |
| Q4 2024 | $563K | -40% |
| Q3 2024 | $578K | -34% |
TWAV's revenue is growing: $522,000 last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -161% | -46 points |
| Q1 2026 | -79% | +32 points |
| Q4 2025 | -126% | +39 points |
| Q3 2025 | -133% | +52 points |
| Q2 2025 | -115% | +51 points |
| Q1 2025 | -111% | +78 points |
| Q4 2024 | -165% | -30 points |
| Q3 2024 | -185% | -79 points |
TWAV's operating margin was −161% last quarter, down 46 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over TWAV on cash flow, with more consistent year-over-year improvement.
TWAV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$539K | -$502K |
| Q1 2026 | -$650K | +$30K |
| Q4 2025 | -$744K | +$141.2K |
| Q3 2025 | -$1.6M | -$643K |
| Q2 2025 | -$37K | +$943K |
| Q1 2025 | -$680K | -$50K |
| Q4 2024 | -$885.2K | -$180.2K |
| Q3 2024 | -$911K | -$805K |
TWAV's free cash flow was −$3M over the past year, against −$3M the year before. Free cash flow isn't a meaningful measure for financial services companies like TWAV.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over TWAV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
TWAV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +240% | +2.8M shares |
| 3 years | +7520% | +3.9M shares |
| 5 years | +44564% | +3.9M shares |
| Available history | +45195% | +3.9M shares |
TWAV has 4M diluted shares, up 240% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $16,000 |
| Q3 2020 | — |
| Q2 2020 | $9,000 |
| Q1 2020 | $7,000 |
| Q4 2019 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
TWAV Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
TWAV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 19.8 | Oversold |
TWAV's weekly RSI is 43 (neutral) and its Stochastic is 20 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
TWAV PE vs Financial Services Sector
TWAV has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over TWAV on trend strength, trading above more of its moving averages.
TWAV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.41 | 12% below |
| 20 week MA | $1.35 | 8.1% below |
| 50 week MA | $1.49 | 17% below |
| 100 week MA | $2.39 | 48% below |
| 200 week MA | $14.6 | 92% below |
TWAV is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over TWAV on returns for 2026, with the stronger performance.
TWAV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $894.0 | $3,306.0 | +270% |
| 2021 | $3,306.0 | $648.0 | -80% |
| 2022 | $648.0 | $72.0 | -89% |
| 2023 | $72.0 | $8.00 | -89% |
| 2024 | $8.00 | $3.88 | -52% |
| 2025 | $3.88 | $1.97 | -49% |
| 2026 YTD | $1.97 | $1.24 | -37% |
TWAV has finished five years in a row lower, and it's down 37% so far in 2026.